New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex.
Saved in:
| Title: | New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex. |
|---|---|
| Authors: | Guillon J; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France., Le Borgne M; Small Molecules for Biological Targets Team, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, CNRS 5286, INSERM 1052, Université Claude Bernard Lyon 1, Univ. Lyon, F-69373 Lyon, France., Milano V; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France., Guédin-Beaurepaire A; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France., Moreau S; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France., Pinaud N; ISM-CNRS UMR 5255, Univ. Bordeaux, F-33405 Talence, France., Ronga L; E2S UPPA, CNRS, IPREM, Université de Pau et des Pays de l'Adour, F-64053 Pau, France., Savrimoutou S; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France., Albenque-Rubio S; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France., Marchivie M; ICMCB-UMR 5026, Univ. Bordeaux, F-33608 Pessac, France., Kalout H; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France., Walker C; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France., Chevallier L; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France., Buré C; CNRS, INSERM, IECB, US1, UAR 3033, Univ. Bordeaux, F-33600 Pessac, France., Largy E; CNRS, INSERM, ARNA, UMR 5320, U1212, IECB, Univ. Bordeaux, F-33600 Pessac, France., Gabelica V; CNRS, INSERM, ARNA, UMR 5320, U1212, IECB, Univ. Bordeaux, F-33600 Pessac, France., Mergny JL; Ecole Polytechnique, Laboratoire d'Optique et Biosciences, CNRS, INSERM, Institut Polytechnique de Paris, F-91120 Palaiseau, France., Baylot V; Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, CNRS UMR7258, Inserm U1068, Univ. Aix Marseille, F-13009 Marseille, France., Ferrer J; INSERM UMR1312, BRIC, Bordeaux Institute of Oncology, Univ. Bordeaux, F-33076 Bordeaux, France., Idrissi Y; INSERM UMR1312, BRIC, Bordeaux Institute of Oncology, Univ. Bordeaux, F-33076 Bordeaux, France., Chevret E; INSERM UMR1312, BRIC, Bordeaux Institute of Oncology, Univ. Bordeaux, F-33076 Bordeaux, France., Cappellen D; INSERM UMR1312, BRIC, Bordeaux Institute of Oncology, Univ. Bordeaux, F-33076 Bordeaux, France.; Service Tumor Biology and Tumor Bank Laboratory, Groupe Hospitalier Bordeaux, CHU Bordeaux, F-33000 Bordeaux, France., Desplat V; INSERM UMR1312, BRIC, Bordeaux Institute of Oncology, Univ. Bordeaux, F-33076 Bordeaux, France., Schelz Z; Institute of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, 6720 Szeged, Hungary., Zupkó I; Institute of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, 6720 Szeged, Hungary. |
| Source: | Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2023 Dec 25; Vol. 17 (1). Date of Electronic Publication: 2023 Dec 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38256866 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Guillon+J%22">Guillon J</searchLink>; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Le+Borgne+M%22">Le Borgne M</searchLink>; Small Molecules for Biological Targets Team, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, CNRS 5286, INSERM 1052, Université Claude Bernard Lyon 1, Univ. Lyon, F-69373 Lyon, France.<br /><searchLink fieldCode="AU" term="%22Milano+V%22">Milano V</searchLink>; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Guédin-Beaurepaire+A%22">Guédin-Beaurepaire A</searchLink>; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Moreau+S%22">Moreau S</searchLink>; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Pinaud+N%22">Pinaud N</searchLink>; ISM-CNRS UMR 5255, Univ. Bordeaux, F-33405 Talence, France.<br /><searchLink fieldCode="AU" term="%22Ronga+L%22">Ronga L</searchLink>; E2S UPPA, CNRS, IPREM, Université de Pau et des Pays de l'Adour, F-64053 Pau, France.<br /><searchLink fieldCode="AU" term="%22Savrimoutou+S%22">Savrimoutou S</searchLink>; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Albenque-Rubio+S%22">Albenque-Rubio S</searchLink>; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Marchivie+M%22">Marchivie M</searchLink>; ICMCB-UMR 5026, Univ. Bordeaux, F-33608 Pessac, France.<br /><searchLink fieldCode="AU" term="%22Kalout+H%22">Kalout H</searchLink>; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Walker+C%22">Walker C</searchLink>; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Chevallier+L%22">Chevallier L</searchLink>; INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Buré+C%22">Buré C</searchLink>; CNRS, INSERM, IECB, US1, UAR 3033, Univ. Bordeaux, F-33600 Pessac, France.<br /><searchLink fieldCode="AU" term="%22Largy+E%22">Largy E</searchLink>; CNRS, INSERM, ARNA, UMR 5320, U1212, IECB, Univ. Bordeaux, F-33600 Pessac, France.<br /><searchLink fieldCode="AU" term="%22Gabelica+V%22">Gabelica V</searchLink>; CNRS, INSERM, ARNA, UMR 5320, U1212, IECB, Univ. Bordeaux, F-33600 Pessac, France.<br /><searchLink fieldCode="AU" term="%22Mergny+JL%22">Mergny JL</searchLink>; Ecole Polytechnique, Laboratoire d'Optique et Biosciences, CNRS, INSERM, Institut Polytechnique de Paris, F-91120 Palaiseau, France.<br /><searchLink fieldCode="AU" term="%22Baylot+V%22">Baylot V</searchLink>; Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, CNRS UMR7258, Inserm U1068, Univ. Aix Marseille, F-13009 Marseille, France.<br /><searchLink fieldCode="AU" term="%22Ferrer+J%22">Ferrer J</searchLink>; INSERM UMR1312, BRIC, Bordeaux Institute of Oncology, Univ. Bordeaux, F-33076 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Idrissi+Y%22">Idrissi Y</searchLink>; INSERM UMR1312, BRIC, Bordeaux Institute of Oncology, Univ. Bordeaux, F-33076 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Chevret+E%22">Chevret E</searchLink>; INSERM UMR1312, BRIC, Bordeaux Institute of Oncology, Univ. Bordeaux, F-33076 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Cappellen+D%22">Cappellen D</searchLink>; INSERM UMR1312, BRIC, Bordeaux Institute of Oncology, Univ. Bordeaux, F-33076 Bordeaux, France.; Service Tumor Biology and Tumor Bank Laboratory, Groupe Hospitalier Bordeaux, CHU Bordeaux, F-33000 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Desplat+V%22">Desplat V</searchLink>; INSERM UMR1312, BRIC, Bordeaux Institute of Oncology, Univ. Bordeaux, F-33076 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Schelz+Z%22">Schelz Z</searchLink>; Institute of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, 6720 Szeged, Hungary.<br /><searchLink fieldCode="AU" term="%22Zupkó+I%22">Zupkó I</searchLink>; Institute of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, 6720 Szeged, Hungary. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101238453%22">Pharmaceuticals (Basel, Switzerland)</searchLink> [Pharmaceuticals (Basel)] 2023 Dec 25; Vol. 17 (1). <i>Date of Electronic Publication: </i>2023 Dec 25. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101238453 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1424-8247 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214248247%22">14248247 </searchLink><i>NLM ISO Abbreviation: </i>Pharmaceuticals (Basel) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38256866 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/ph17010030 Languages: – Code: eng Text: English Titles: – TitleFull: New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Guillon J – PersonEntity: Name: NameFull: Le Borgne M – PersonEntity: Name: NameFull: Milano V – PersonEntity: Name: NameFull: Guédin-Beaurepaire A – PersonEntity: Name: NameFull: Moreau S – PersonEntity: Name: NameFull: Pinaud N – PersonEntity: Name: NameFull: Ronga L – PersonEntity: Name: NameFull: Savrimoutou S – PersonEntity: Name: NameFull: Albenque-Rubio S – PersonEntity: Name: NameFull: Marchivie M – PersonEntity: Name: NameFull: Kalout H – PersonEntity: Name: NameFull: Walker C – PersonEntity: Name: NameFull: Chevallier L – PersonEntity: Name: NameFull: Buré C – PersonEntity: Name: NameFull: Largy E – PersonEntity: Name: NameFull: Gabelica V – PersonEntity: Name: NameFull: Mergny JL – PersonEntity: Name: NameFull: Baylot V – PersonEntity: Name: NameFull: Ferrer J – PersonEntity: Name: NameFull: Idrissi Y – PersonEntity: Name: NameFull: Chevret E – PersonEntity: Name: NameFull: Cappellen D – PersonEntity: Name: NameFull: Desplat V – PersonEntity: Name: NameFull: Schelz Z – PersonEntity: Name: NameFull: Zupkó I IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 12 Text: 2023 Dec 25 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 1424-8247 Numbering: – Type: volume Value: 17 – Type: issue Value: 1 Titles: – TitleFull: Pharmaceuticals (Basel, Switzerland) Type: main |
| ResultId | 1 |
